Table II.
miR-124a multivariate analysis | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Factor | HR | 95% CI (univariate) | P-value | HR | 95% CI (multivariate) | P-value | ||||
Age | 0.96 | 0.69–1.14 | 0.45 | |||||||
Gender | 0.87 | 0.53–1.16 | 0.18 | |||||||
Smoking history | 1.21 | 0.71–1.52 | 0.19 | |||||||
Lymph-node metastasis | 1.72 | 1.18–2.96 | 0.03 | 1.98 | 1.25–3.03 | 0.015 | ||||
Tumor differentiation | 0.88 | 0.54–1.01 | 0.18 | |||||||
Histology | 1.18 | 0.86–1.21 | 0.34 | |||||||
TNM stage | 1.83 | 1.56–2.64 | 0.02 | 2.13 | 1.61–2.89 | 0.009 | ||||
Invasion of lung membrane | 1.22 | 1.06–1.37 | 0.15 | |||||||
Vascular invasion | 0.98 | 0.68–1.54 | 0.31 | |||||||
Diameter | 2.56 | 2.07–5.46 | <0.001 | 3.65 | 2.26–5.43 | <0.001 | ||||
miR-124a expression | 0.68 | 0.52–0.73 | 0.023 |
HR, hazard ratio; miR-124a, microRNA-124a; CI, confidence interval; TNM, tumor node metastasis.